Riskpilot← Back to searchSign inGet full accessMEDY AS
ASActiveOrg 926582070Fiskeklevveien 19, 1769 HaldenPhysiotherapy activities · NACE 8695Est. 20210 employees
Revenue 2024
NOK 8,6M
+39% vs 2023
EBITDA margin
-5.2%
-527% vs 2023
Equity ratio
-10.5%
Financial strength
Net profit 2024
NOK -440K
-628% vs 2023
| Revenue | NOK 8,6M | +39% |
| EBITDA | NOK -444K | -527% |
| Net profit | NOK -440K | -628% |
| Total assets | NOK 472K | +14% |
| Equity | NOK -50K | -113% |
| Employees | 0 | — |
Legal name
MEDY AS
Org number
926582070
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
12. februar 2021
Share capital
NOK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder eller styrets leder hver for seg.
Company purpose
Hjemmebasert fysioterapitjeneste. Levere fysioterapitjenester hjem til pasienten.
Address
Fiskeklevveien 19, 1769 Halden
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 670 | 2 741 | 6 153 | 8 555 |
| Staff expenses | −0 | −0 | −29 | −71 |
| EBITDA | 139 | 96 | 104 | −444 |
| Depreciation & amort. | −0 | −0 | −0 | −0 |
| EBIT | 139 | 96 | 104 | −444 |
| Net financials | −7 | −0 | 3 | 4 |
| Profit before tax | 132 | 95 | 107 | −440 |
| Tax | 29 | 21 | 23 | −0 |
| Net profit | 103 | 74 | 83 | −440 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 272 | 328 | 414 | 472 |
| Equity | 133 | 307 | 391 | −50 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 139 | 21 | 23 | 521 |
| Total debt | 139 | 21 | 23 | 521 |
EBITDA margin
-5.2%
This company
15.8%
Market median
-133% vs market
20212024
Equity ratio
-10.5%
This company
38.2%
Market median
-127% vs market
20212024
Return on equity
-44025200.0%
This company
18.4%
Market median
-239267491% vs market
20212024
Net profit margin
-5.1%
This company
8.1%
Market median
-163% vs market
20212024
Asset turnover
18.13×
This company
1.12×
Market median
+1519% vs market
20212024
Debt / equity
10.53×
This company
0.62×
Market median
-1598% vs market
20212024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Eyki Invest As | Company | 47.0% | 47.0% | 2024 |
As Østenfjeldske Merkantile Bureau | Company | 20.0% | 20.0% | 2024 |
Bluefin Invest As | Company | 20.0% | 20.0% | 2024 |
| Individual | 10.0% | 10.0% | 2022 | |
| Individual | 10.0% | 10.0% | 2024 | |
| Individual | 10.0% | 10.0% | 2022 | |
| Individual | 3.0% | 3.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MEDY AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Inger Lise Egeberg Strandin | Board of Directors | 0 companies |
| Sindre Strandin | Board of Directors | 0 companies |
| Peder Eyde Kielland | Chairman | 0 companies |
| Carl Christian Hansson | Board of Directors | 0 companies |